DT Form 144 Filed for 7,506-Share Sale; Broker Morgan Stanley Listed
Rhea-AI Filing Summary
Dynatrace, Inc. (DT) Form 144 notifies a proposed sale of 7,506 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $373,306.41, and an approximate sale date of 09/09/2025. The filing lists 301,506,242 shares outstanding. The shares to be sold were acquired on 09/05/2025 as 4,651 performance shares and 2,855 restricted stock. The filing also discloses a prior sale by Daniel J. Zugelder of 15,822 shares on 07/01/2025 for $867,702.21. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
Positive
- Transaction disclosed under Rule 144, indicating regulatory compliance
Negative
- None.
Insights
TL;DR Routine insider notice of proposed sale; disclosed acquisition dates and a recent larger sale are provided.
The Form 144 details a small proposed disposition relative to the issuer's outstanding shares: 7,506 shares versus 301,506,242 outstanding. The filing records that the securities were awarded on 09/05/2025 as performance shares and restricted stock, indicating these are insider compensation-related disposals rather than open-market purchases. The filing also reports a prior sale of 15,822 shares on 07/01/2025 for $867,702.21, which is documented for aggregation purposes. Overall this is a compliance disclosure under Rule 144 without standalone financial metrics or forward-looking statements.
TL;DR Compliance-focused disclosure showing insider sales tied to compensation vesting; no material nonpublic information asserted.
The notice includes required representations about material information and references possible reliance on trading plans. The timing—acquisition on 09/05/2025 and proposed sale on 09/09/2025—suggests vesting-triggered sales. Disclosure of the broker and exact aggregate market value meets regulatory transparency expectations. There are no allegations or indicators of governance issues in the text; the form is procedural and aimed at regulatory compliance.
FAQ
What securities does Dynatrace's Form 144 (DT) propose to sell?
When is the proposed sale date listed on the Form 144 for DT?
What is the aggregate market value and who is the broker on the Form 144?
How many shares outstanding does the filing state for Dynatrace?
Were the shares being sold recently acquired and how?
Does the Form 144 disclose any prior sales by the same person?